No Data
ADRs End Higher; Yunji Inc. Climbs 38%
BioLineRx Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Express News | As Of June 30, 2024, BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $40.1M Expected To Be Sufficient To Fund Operations, As Currently Planned, Into 2025
Express News | BioLine Rx Q2 2024 GAAP EPS $0.00 Beats $(0.14) Estimate, Sales $5.393M Beat $3.930M Estimate
Express News | BioLine RX Ltd: Sees Qtr-End Cash to Fund Operations Into 2025
Express News | BioLine RX Ltd: Qtrly Revenue $5.4 Mln
No Data
.
Mooers Lab : Great screenshot!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Add a quick analysis (30+ words) to join the 30,000 point pool! More entries (up to 10) = more points! Bonus: Share P/L for an extra 200 points!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
For full details, check "Rewards for sharing" athttps://www.moomoo.com/community/feed/112812180045830